Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01842958 · ClinicalTrials.gov registry record · NA

Straumann Roxolid Multi-Center Study

A NA study of Jaw, Edentulous, Partially, sponsored by Institut Straumann.

Completed
Registry status
NA
Development phase
50
Enrollment target
5
Study locations

NCT01842958 is a NA study of Jaw, Edentulous, Partially that has completed, run by Institut Straumann. The registered enrollment target is 50 participants, below the 126-participant average among 5 other Jaw, Edentulous, Partially trials with a reported enrollment target (60% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01842958, a NA study of Jaw, Edentulous, Partially, has completed, sponsored by Institut Straumann.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
5
Study locations

Study Summary

The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone Level Ø 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level Ø 4.1 mm RC SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery and 12 months post-implant placement. The secondary objectives will assess differences in clinical outcomes between the test and control implants, including implant success and survival, gingival recession, subject satisfaction and additional early bone level measurements.

Conditions Studied

Interventions

  • DEVICE Straumann Bone Level Implants, 4.1 mm implant diameter
  • DEVICE Straumann Bone Level Implants, 3.3 mm implant diameter

Study Locations (5)

California

  • UCLA School of Dentistry - Los Angeles

Massachusetts

  • Boston University, School of Dental Medicine - Boston

New York

  • New York University College of Dentistry - New York

Texas

  • Univeristy of Texas Health Science Center San Antonio - San Antonio

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2013-03
Est. Completion 2016-03
Phase NA

Sponsor

Institut Straumann

7 total trials

What the Registry Record Tells You About NCT01842958

The ClinicalTrials.gov registry entry for NCT01842958 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 126-participant average among 5 other Jaw, Edentulous, Partially trials with a reported enrollment target (60% lower). The listed sponsor is Institut Straumann, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Jaw, Edentulous, Partially appearing as the primary indexed condition, and to 2 interventions - of which Straumann Bone Level Implants, 4.1 mm implant diameter is the first listed.

NCT01842958 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Massachusetts, New York.

Frequently Asked Questions

What is clinical trial NCT01842958 about?

NCT01842958 is a clinical study titled "Straumann Roxolid Multi-Center Study". The primary objective of this study is to demonstrate non-inferiority of the Straumann Bone Level Ø 3.3 mm NC SLActive Roxolid Implants compared to Straumann Bone Level Ø 4.1 mm RC SLActive Roxolid Implants based on mean crestal bone level changes measured between surgery and 12 months post-implant ...

What is the current status of trial NCT01842958?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2013-03. Estimated completion is 2016-03.

What conditions does trial NCT01842958 study?

This clinical trial studies the following conditions: Jaw, Edentulous, Partially.

What interventions are being tested in trial NCT01842958?

The interventions under investigation include: Straumann Bone Level Implants, 4.1 mm implant diameter (DEVICE), Straumann Bone Level Implants, 3.3 mm implant diameter (DEVICE).

Who is sponsoring clinical trial NCT01842958?

This trial is sponsored by Institut Straumann, which has 7 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01842958 being conducted?

This trial has 5 study locations across California, Massachusetts, New York, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Jaw, Edentulous, Partially

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.